Company intelligence / Profile preview
Yichang Humanwell Pharmaceutical Co., Ltd.
Yichang, Hubei, Chinahumanwellpharma.com ↗
- Ownership
- Private
- Employees
- ~4700
- Development stage
- Commercial
01
Overview
The company has multiple approved products in the market, particularly in anesthetics and pain management. It has received GMP certifications from various regulatory bodies including US FDA, UK MHRA, and China's CFDA.
- Therapeutic areas
- GastroenterologyHematologyNeurologyInfectious Diseases
- Modalities
- Small molecule drugsChemical drugsSynthetic peptide
- Industry
- Pharma
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
Sinopharm Group Co., Ltd. (holds 20% of Yichang Humanwell's stock shares)
Beyond the preview
Go deeper on Yichang Humanwell Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yichang Humanwell Pharmaceutical Co., Ltd..